Research / WAT / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-26-344691 General Corporate
Debt relative to revenue 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
309.18% · OPTIONAL · VALID
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.92% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.22% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
113.27% · CORE · VALID
Inventory pressure 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
83.71% · OPTIONAL · VALID
Operating margin 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-5.23% · CORE · VALID
R&D intensity 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.42% · OPTIONAL · VALID
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.52% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 48 states Self-history eligible
Oct 2, 2021 7/7 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Apr 2, 2022 7/7 normalized Level 3 Jul 2, 2022 7/7 normalized Level 3 Oct 1, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Apr 1, 2023 7/7 normalized Level 3 Jul 1, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 30, 2024 6/6 normalized Level 3 Jun 29, 2024 7/7 normalized Level 3 Sep 28, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 29, 2025 7/7 normalized Level 3 Jun 28, 2025 7/7 normalized Level 3 Sep 27, 2025 7/7 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Apr 4, 2026 7/8 normalized Level 3 Jul 4, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 411.60%
Current 309.18%
Delta -102.42% Capex Intensity Decreased
Previous 3.08%
Current 2.92%
Delta -0.16% Cash Generation Increased
Previous -0.24%
Current 12.22%
Delta 12.46% Growth Increased
Previous 91.48%
Current 113.27%
Delta 21.79% Inventory Pressure Decreased
Previous 118.07%
Current 83.71%
Delta -34.37% Profitability Decreased
Previous -3.71%
Current -5.23%
Delta -1.52% R And D Intensity Decreased
Previous 7.58%
Current 7.42%
Delta -0.16% Sbc Intensity Decreased
Previous 1.58%
Current 1.52%
Delta -0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Apr 4, 2026
Similarity 88%
Compared 7 dimensions
Coverage 100% Growth 0.0 · Profitability 0.0 · Sbc Intensity 5.0 · Cash Generation 25.0 · R And D Intensity 5.0 · Inventory Pressure 10.0 · Balance Sheet Leverage 15.0 Apr 1, 2017
Similarity 81%
Compared 5 dimensions
Coverage 71% Profitability 11.1 · Sbc Intensity 11.7 · R And D Intensity 28.3 · Inventory Pressure 23.3 · Balance Sheet Leverage 15.0 Oct 1, 2022
Similarity 78%
Compared 7 dimensions
Coverage 100% Growth 25.0 · Profitability 15.0 · Sbc Intensity 30.0 · Cash Generation 6.3 · R And D Intensity 30.0 · Inventory Pressure 10.0 · Balance Sheet Leverage 25.0 Jul 1, 2023
Similarity 74%
Compared 7 dimensions
Coverage 100% Growth 50.0 · Profitability 20.0 · Sbc Intensity 20.0 · Cash Generation 25.0 · R And D Intensity 25.0 · Inventory Pressure 0.0 · Balance Sheet Leverage 10.0 Jun 28, 2025
Similarity 70%
Compared 7 dimensions
Coverage 100% Growth 25.0 · Profitability 10.0 · Sbc Intensity 25.0 · Cash Generation 20.0 · R And D Intensity 20.0 · Inventory Pressure 20.0 · Balance Sheet Leverage 60.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.